Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Cost of Revenue | |||||||
Gross Profit | |||||||
Gross Profit Margin (%) | |||||||
R&D Expense | |||||||
SG&A Expense | |||||||
Total Operating Expenses | |||||||
Operating Income or Loss | |||||||
Operating Margin (%) | |||||||
Interest Expense | |||||||
Total Other Income/Expenses | |||||||
Income Before Tax | |||||||
Income Tax Expense | |||||||
Income from Continuing Ops. | |||||||
Net Income | |||||||
Net Profit Margin (%) | |||||||
Net Income available to common shareholders | |||||||
Basic EPS | |||||||
Diluted EPS | |||||||
Basic Average Shares | |||||||
Diluted Average Shares |
Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | Jun 2015 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||||||
Cost of Revenue | ||||||||||||||||||
Gross Profit | ||||||||||||||||||
Gross Profit Margin (%) | ||||||||||||||||||
R&D Expense | ||||||||||||||||||
SG&A Expense | ||||||||||||||||||
Total Operating Expenses | ||||||||||||||||||
Operating Income or Loss | ||||||||||||||||||
Operating Margin (%) | ||||||||||||||||||
Interest Expense | ||||||||||||||||||
Total Other Income/Expenses | ||||||||||||||||||
Income Before Tax | ||||||||||||||||||
Income Tax Expense | ||||||||||||||||||
Income from Continuing Ops. | ||||||||||||||||||
Net Income | ||||||||||||||||||
Net Profit Margin (%) | ||||||||||||||||||
Net Income available to common shareholders | ||||||||||||||||||
Basic EPS | ||||||||||||||||||
Diluted EPS | ||||||||||||||||||
Basic Average Shares | ||||||||||||||||||
Diluted Average Shares |
Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|
Current Assets | |||||||
Cash & Cash Equivalents | |||||||
Marketable Securities | |||||||
Receivables | |||||||
Inventories | |||||||
Other Current Assets | |||||||
Total Current Assets | |||||||
Non-Current Assets | |||||||
Marketable Securities | |||||||
PPE Net | |||||||
Intangibles inc. Goodwill | |||||||
Other Non-Current Assets | |||||||
Total Non-Current Assets | |||||||
Total Assets | |||||||
Current Liabilities | |||||||
Accounts Payable | |||||||
Deferred Revenues | |||||||
Debt, Current | |||||||
Accrued Liabilities | |||||||
Other Current Liabilities | |||||||
Total Current Liabilities | |||||||
Non-Current Liabilities | |||||||
Deferred Revenues | |||||||
Debt, Non-Current | |||||||
Other Non-Current Liabilities | |||||||
Total Non-Current Liabilities | |||||||
Total Liabilities | |||||||
Shareholders' Equity | |||||||
Common Stock | |||||||
Additional Paid-In Capital | |||||||
Retained Earnings | |||||||
Other Shareholders' Equity | |||||||
Total Shareholders' Equity | |||||||
Total Liabilities & Shareholders' Equity |
Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | Jun 2015 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||||||
Cash & Cash Equivalents | ||||||||||||||||||
Marketable Securities | ||||||||||||||||||
Receivables | ||||||||||||||||||
Inventories | ||||||||||||||||||
Other Current Assets | ||||||||||||||||||
Total Current Assets | ||||||||||||||||||
Non-Current Assets | ||||||||||||||||||
Marketable Securities | ||||||||||||||||||
PPE Net | ||||||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||||||
Other Non-Current Assets | ||||||||||||||||||
Total Non-Current Assets | ||||||||||||||||||
Total Assets | ||||||||||||||||||
Current Liabilities | ||||||||||||||||||
Accounts Payable | ||||||||||||||||||
Deferred Revenues | ||||||||||||||||||
Debt, Current | ||||||||||||||||||
Accrued Liabilities | ||||||||||||||||||
Other Current Liabilities | ||||||||||||||||||
Total Current Liabilities | ||||||||||||||||||
Non-Current Liabilities | ||||||||||||||||||
Deferred Revenues | ||||||||||||||||||
Debt, Non-Current | ||||||||||||||||||
Other Non-Current Liabilities | ||||||||||||||||||
Total Non-Current Liabilities | ||||||||||||||||||
Total Liabilities | ||||||||||||||||||
Shareholders' Equity | ||||||||||||||||||
Common Stock | ||||||||||||||||||
Additional Paid-In Capital | ||||||||||||||||||
Retained Earnings | ||||||||||||||||||
Other Shareholders' Equity | ||||||||||||||||||
Total Shareholders' Equity | ||||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||
Net Income | |||||||
Depreciation & Amortization | |||||||
Deferred Income Taxes | |||||||
Stock Based Compensation | |||||||
Accounts Receivable | |||||||
Inventory | |||||||
Accounts Payable | |||||||
Deferred Revenue | |||||||
Other Non-Cash | |||||||
Operating Cash Flow | |||||||
Cash Flows from Investing Activities | |||||||
PPE Investments | |||||||
Net Acquisitions | |||||||
Purchase of Investments | |||||||
Sale of Investments | |||||||
Other Investing Activity | |||||||
Investing Cash Flow | |||||||
Cash Flows from Financing Activities | |||||||
Debt Issued | |||||||
Proceeds from Debt Repayment | |||||||
Debt Repayment | |||||||
Proceeds from Sale of Equity | |||||||
Equity Repurchased | |||||||
Dividend Paid | |||||||
Other Financing Activity | |||||||
Financing Cash Flow | |||||||
Cash Position | |||||||
Beginning Cash Position | |||||||
End Cash Position | |||||||
Change in Cash | |||||||
Free Cash Flow | |||||||
Operating Cash Flow | |||||||
Capital Expenditure | |||||||
Free Cash Flow |
Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | Jun 2015 | Mar 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||||||
Net Income | ||||||||||||||||||
Depreciation & Amortization | ||||||||||||||||||
Deferred Income Taxes | ||||||||||||||||||
Stock Based Compensation | ||||||||||||||||||
Accounts Receivable | ||||||||||||||||||
Inventory | ||||||||||||||||||
Accounts Payable | ||||||||||||||||||
Deferred Revenue | ||||||||||||||||||
Other Non-Cash | ||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||||||
PPE Investments | ||||||||||||||||||
Net Acquisitions | ||||||||||||||||||
Purchase of Investments | ||||||||||||||||||
Sale of Investments | ||||||||||||||||||
Other Investing Activity | ||||||||||||||||||
Investing Cash Flow | ||||||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||||||
Debt Issued | ||||||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||||||
Debt Repayment | ||||||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||||||
Equity Repurchased | ||||||||||||||||||
Dividend Paid | ||||||||||||||||||
Other Financing Activity | ||||||||||||||||||
Financing Cash Flow | ||||||||||||||||||
Cash Position | ||||||||||||||||||
Beginning Cash Position | ||||||||||||||||||
End Cash Position | ||||||||||||||||||
Change in Cash | ||||||||||||||||||
Free Cash Flow | ||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||
Capital Expenditure | ||||||||||||||||||
Free Cash Flow |